Literature DB >> 10775731

Computed tomography in endometrial carcinoma.

J P Connor1, J I Andrews, B Anderson, R E Buller.   

Abstract

OBJECTIVE: To determine the value of computed tomography (CT) scans for preoperatively detecting extrauterine-nodal disease and postoperative recurrent disease in patients with endometrial cancer.
METHODS: We reviewed records of 702 women with primary endometrial carcinoma that was diagnosed between 1979 and 1993. Preoperative CT findings were compared with pathologic findings to assess nodal disease. The yield of postoperative CT was reviewed in clinically suspicious and routine settings.
RESULTS: Among 492 women eligible for analysis, 178 (36%) had a total 326 CT scans. Among 56 women who had preoperative CT scans and lymph node samplings, positive and negative predictive values for nodal involvement were 50% and 94%, respectively, and sensitivity and specificity were 57% and 92%, respectively. Preoperative CT findings altered treatment plans in only six patients (8%). Forty-five asymptomatic women had 73 routine CT scans, and recurrence was diagnosed by CT in only two (4.4%). Thirty-seven women had CT scans for suspicion of recurrence, which was confirmed in 17 (46%). Kaplan-Meyer analysis showed no survival advantage in women with subclinical recurrences diagnosed by CT scan.
CONCLUSION: Routine preoperative CT scanning rarely alters treatment and is a poor predictor of nodal disease. Computed tomography in the postoperative period might be helpful for detection and follow-up of recurrent disease, but there was no difference in survival when subclinical recurrence was found by CT. Thus, CT scanning of any woman with endometrial cancer should be discouraged unless it is to evaluate symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 10775731     DOI: 10.1016/s0029-7844(99)00626-2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

1.  Patterns and utility of routine surveillance in high grade endometrial cancer.

Authors:  Jessica Hunn; Meaghan E Tenney; Ana I Tergas; Erin A Bishop; Kathleen Moore; William Watkin; Carolyn Kirschner; Jean Hurteau; Gustavo C Rodriguez; Ernst Lengyel; Nita K Lee; S Diane Yamada
Journal:  Gynecol Oncol       Date:  2015-03-30       Impact factor: 5.482

2.  Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus.

Authors:  Yulia Lakhman; Seth S Katz; Debra A Goldman; Derya Yakar; Hebert A Vargas; Ramon E Sosa; Maura Miccò; Robert A Soslow; Hedvig Hricak; Nadeem R Abu-Rustum; Evis Sala
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

3.  Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.

Authors:  Katherine I Stewart; Beth Chasen; William Erwin; Nicole Fleming; Shannon N Westin; Shayan Dioun; Michael Frumovitz; Pedro T Ramirez; Karen H Lu; Franklin Wong; Thomas A Aloia; Pamela T Soliman
Journal:  Cancer       Date:  2019-06-21       Impact factor: 6.860

4.  The guidance of intraoperative frozen section for staging surgery in endometrial carcinoma: frozen section in endometrial carcinoma.

Authors:  Arbil Acikalin; Derya Gumurdulu; Emine Kilic Bagir; Goncagül Torun; Ahmet Baris Guzel; Handan Zeren; Mehmet Ali Vardar
Journal:  Pathol Oncol Res       Date:  2014-05-20       Impact factor: 3.201

5.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

Review 6.  Society of gynecologic oncology future of physician payment reform task force: Lessons learned in developing and implementing surgical alternative payment models.

Authors:  Margaret I Liang; Emeline M Aviki; Jason D Wright; Laura J Havrilesky; Leslie R Boyd; Haley A Moss; Elizabeth L Jewell; David E Cohn; Sachin M Apte; Patrick F Timmins; Ronald D Alvarez; Jill Rathbun; Elizabeth Lipinski; Susan White; Dorimar Siverio-Minardi; Emily M Ko
Journal:  Gynecol Oncol       Date:  2020-01-06       Impact factor: 5.482

7.  Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Kaji; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2009-01-29       Impact factor: 5.315

8.  Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2008-04-19       Impact factor: 5.315

9.  Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Satoru Morita; Narufumi Suganuma; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-18       Impact factor: 9.236

10.  Usefulness of F-18 FDG PET/CT in Assessment of Recurrence of Cervical Cancer After Treatment.

Authors:  Minkyung Lee; Yukyung Lee; Kyung Hoon Hwang; Wonsick Choe; Chan Yong Park
Journal:  Nucl Med Mol Imaging       Date:  2011-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.